Clinical-stage biopharmaceutical firm developing mitochondria-based therapeutics to treat chronic diseases and extend healthy lifespan, CohBar Inc (NASDAQ:CWBR) saw stock prices zoom by 26% on August 11, 2021. Investors cheered on the firm’s topline results from the multi-center, randomized, placebo-controlled Phase 1a/1b clinical study of CB4211, under development for nonalcoholic steatohepatitis and obesity. According to the …
Continue reading “CohBar Inc (NASDAQ:CWBR) Stock Gains Further Momentum: Are You Excited?”